Population pharmacokinetic and exposure‐response analysis of eptinezumab in the treatment of episodic and chronic migraine

Eptinezumab is a humanized mAb that targets calcitonin gene‐related peptide and is under regulatory review for the prevention of episodic and chronic migraine (EM, CM). It is important to determine whether exposures achieved with intravenous (IV) administration of eptinezumab achieve desired pharmac...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Brian, Schaeffler, Barbara, Beliveau, Martin, Rubets, Igor, Pederson, Susan, Trinh, MyMy, Smith, Jeff, Latham, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064329/
https://www.ncbi.nlm.nih.gov/pubmed/32155317
http://dx.doi.org/10.1002/prp2.567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064329/
https://www.ncbi.nlm.nih.gov/pubmed/32155317
http://dx.doi.org/10.1002/prp2.567

Ejemplares similares